PPAR? agonists promote oligodendrocyte differentiation of neural stem cells by modulating stemness and differentiation genes.
Ontology highlight
ABSTRACT: Neural stem cells (NSCs) are a small population of resident cells that can grow, migrate and differentiate into neuro-glial cells in the central nervous system (CNS). Peroxisome proliferator-activated receptor gamma (PPAR?) is a nuclear receptor transcription factor that regulates cell growth and differentiation. In this study we analyzed the influence of PPAR? agonists on neural stem cell growth and differentiation in culture. We found that in vitro culture of mouse NSCs in neurobasal medium with B27 in the presence of epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) induced their growth and expansion as neurospheres. Addition of all-trans retinoic acid (ATRA) and PPAR? agonist ciglitazone or 15-Deoxy-?(12,14)-Prostaglandin J(2) (15d-PGJ2) resulted in a dose-dependent inhibition of cell viability and proliferation of NSCs in culture. Interestingly, NSCs cultured with PPAR? agonists, but not ATRA, showed significant increase in oligodendrocyte precursor-specific O4 and NG2 reactivity with a reduction in NSC marker nestin, in 3-7 days. In vitro treatment with PPAR? agonists and ATRA also induced modest increase in the expression of neuronal ?-III tubulin and astrocyte-specific GFAP in NSCs in 3-7 days. Further analyses showed that PPAR? agonists and ATRA induced significant alterations in the expression of many stemness and differentiation genes associated with neuro-glial differentiation in NSCs. These findings highlight the influence of PPAR? agonists in promoting neuro-glial differentiation of NSCs and its significance in the treatment of neurodegenerative diseases.
SUBMITTER: Kanakasabai S
PROVIDER: S-EPMC3503969 | biostudies-literature | 2012
REPOSITORIES: biostudies-literature
ACCESS DATA